Pharma Mar saw the highest growth of 1.99% in patent filings and no patents were granted in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 1.99% and no change in grants. GlobalData’s DataBook provides a comprehensive analysis of Pharma Mar‘s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Pharma Mar has been focused on protecting inventions in Australia(AU) with two publications in Q2 2024
The Australia(AU) Patent Office dominates the patent filings with nearly 29% of filings. The Australia(AU), United States(US), Hungary(HU), and Israel(IL) patent Office are among the top ten patent offices where Pharma Mar is filings its patents..
Roche and Johnson & Johnson could be the strongest competitors for Pharma Mar
Patents related to rare diseases and climate change lead Pharma Mar's portfolio
Pharma Mar has the highest number of patents in rare diseases followed by, climate change and nanomedicine. For rare diseases, nearly 60% of patents were filed and no patents were granted in Q2 2024.
Small-cell lung cancer related patents lead Pharma Mar portfolio followed by colorectal tumor, and lung cancer
Pharma Mar has highest number of patents in small-cell lung cancer followed by colorectal tumor, lung cancer, ovarian cancer, and sarcomas.
For comprehensive analysis of Pharma Mar's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
